2025-520461-41-00
CTIS ↗
AB-101-05
Systemic Sclerosis (SSc), Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs), Sjögren’s Disease (SjD)
biotech · Lupus Nephritis - WHO Class III · Non Hodgkin Lymphoma · ARTV
Artiva Biotherapeutics
Artiva Biotherapeutics trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
San Diego, USA HQ
2019 Founded
105 Employees
Public company Type
ARTV · NYSE Ticker
Company details
- Status
- Public
- HQ
- San Diego, USA
- Founded
- 2019
- Employees
- 105
- Programs
- 8
- Drugs
- 9
- Patents
- 0
Artiva Biotherapeutics clinical trials
Registry index of 8 ClinicalTrials.gov studies linked to Artiva Biotherapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Artiva Biotherapeutics trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Artiva Biotherapeutics.